<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100
Image Overlay - NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics Will Proceed with COVID-19 trial of RLF-100

NeuroRx and Relief Therapeutics were given the go-ahead from the independent Data Monitoring Committee (DMC) to continue their Phase IIb/III trial of RLF-100 (aviptadil) to treat respiratory failure in critically ill patients with Covid-19. No safety concerns were identified, allowing the trial will continue as planned to meet the full enrolment of 165 patients. When it comes to shipments, Yourway works at all hours to ensure that our couriers are available whenever needed – that includes picking up shipments 24/7, including weekends and holidays, with no cut-off times and no hidden fees.

Back to Index
Media

Upcoming Events

Precision in Pharma Supply Chain & Logistics Summit (Munich)

April 15-16, 2024
Science Congress Center Munich

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Media

Articles

The At-home Trial Experience: Leveraging value-chain to reach and retain patients

Open chat
Come chat with us!
Hello! How can I help you?